Monday 28 March 2016

Genomics In Cancer Care Industry Share and Size, Market Analysis, Trends and Growth, End-use And Segment Forecasts To 2022

Global genomics in cancer care market is expected to reach USD 9.22 billion by 2022, according to a new report by Grand View Research, Inc. Increasing prevalence of cancer coupled with adoption of next generation sequencing for the diagnosis & treatment is expected to fuel the market with future growth opportunities. Increasing incidences of cancer triggers the demand for cost effective and accurate diagnostics in coming years.

In addition, increasing demand for personalized medicines in molecular characterization of cancer to identify therapeutic targets is the factor attributing towards the market growth. Similarly, factors such as cost reduction in genome sequencing, growing healthcare expenditure levels and development of effective diagnostics & therapeutic procedures for cancer are responsible for the potential growth of genomics in cancer care.


Further key findings from the study suggest:
Instrument segment dominated the overall market in terms of revenue share as of 2014 and accounted for 33.4% of market owing to high cost associated with it. Whereas, consumables are most widely used product segment in genome testing as they are indispensible component and frequently required to perform the test.

Demand for services such as next generation sequencing, PCR and other such as cancer risk management & genetic testing are expected to grow over the forecast period due to increasing outsourcing activities to perform genome analysis. High cost of performing genetic tests and growing awareness pertaining to associated benefits with the use of these technologies are high impact rendering drivers for this segment.



Drug discovery and development segment is expected to show lucrative CAGR of 17.6% during the forecast period owing to increasing demand for effective treatment for cancer and growing investment in biomedicines by manufacturers for the development of novel products.

Request A Sample copy of This Report @ http://www.hexareports.com/sample/98212

Table Of Content

Chapter 1. Methodology and Scope
1.1. Research methodology
1.2. Research scope & assumptions
1.3. List of data sources

Chapter 2. Executive Summary
2.1. Genomics in cancer care- Industry Snapshot And Key Buying Criteria, 2012-2022

Chapter 3. Genomics In Cancer Care Industry Outlook
3.1. Genomics in cancer care market segmentation
3.2. Genomics in cancer care market size and growth prospects
3.3. Genomics in cancer care market dynamics
3.4. Key opportunities prioritized
3.5. Industry Analysis - Porter's

Chapter 4. Genomics In Cancer Care Product Outlook
4.1. Genomics in cancer care market share by product, 2014 & 2022
4.2. Instruments
4.3. Consumables & reagents
4.4. Services

Contact Information:

Ryan Shaw

Felton Office Plaza,
6265 Highway 9,
Felton, California, 95018,
United States
Phone Number
1-800-489-3075

No comments:

Post a Comment